🕵️ SKYE Bioscience, Inc. ($SKYE)
SEC insider & ownership activity, last 12 months · CIK 1516551 · every row links its SEC filing
Over the last 12 months insiders sold $1.6M with no open-market buying against it. Andrew J. Schwab sold $801K (Aug). 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), May 13, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $1.6M (8 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Andrew J. Schwab | 0 | – | 4 | $801K | Aug 22, 2025 |
| 5AM Partners VII, LLC | 0 | – | 4 | $801K | Aug 22, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Andrew J. Schwab | 34.0% | 13D | Dec 12, 2025 | filing ↗ | |
| Kush Parmar | 29.2% | 13D | Dec 12, 2025 | filing ↗ | |
| 5AM Partners VII, LLC | 29.2% | 13D | Dec 12, 2025 | filing ↗ | |
| 5AM Ventures VII, L.P. | 29.2% | 13D | Dec 12, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jun 18, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 26, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Delisting notice (3.01) | May 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 31, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 17, 2026 | filing ↗ |
| Earnings (2.02) | Mar 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 2, 2026 | filing ↗ |
| Other events (8.01) | Feb 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 2, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 18, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |